Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Emma, MR"'
Autor:
Giannitrapani, L, Soresi, M, Guercio, G, Cabibi, D, Porcasi, R, Giglio, RV, Lazzaro, L, Emma, MR, Cervello, M, Pantuso, G, Montalto, G
FIBROSIS DIAGNOSTIC SCORES VALIDATION IN OBESE PATIENTS WITH NON-ALCOHOLIC LIVER DISEASE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::a2b511f5e2e1750e753dacf22a2c7f06
http://hdl.handle.net/10447/332929
http://hdl.handle.net/10447/332929
Autor:
Kapadia, Malika1, Perentesis, Emma MR1, Lane, Adam1, Dandoy, Christopher E1, Davies, Stella M.1
Publikováno v:
Biology of Blood & Marrow Transplantation. 2019 Supplement, Vol. 25 Issue 3, pS346-S346. 1p.
Autor:
Maria Rita Emma, Antonella Cusimano, Karen Blyth, Maurizio Soresi, Melchiorre Cervello, Angela Listi, Daniela Cabibi, Christopher L. Pin, Sergiu Coslet, Rossana Porcasi, Gianni Pantuso, Marion Rubis, Giuseppa Augello, Juan L. Iovanna, Maria Teresa Borrello, Lydia Giannitrapani, Giuseppe Montalto
Publikováno v:
Paediatrics Publications
The FASEB journal (Online) 35 (2021): e21395. doi:10.1096/fj.202002413RR
info:cnr-pdr/source/autori:Teresa Borrello M; Rita Emma M; Listi A; Rubis M; Coslet S; Augello G; Cusimano A; Cabibi D; Porcasi R; Giannitrapani L; Soresi M; Pantuso G; Blyth K; Montalto G; Pin C; Cervello M; Iovanna J;/titolo:NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response/doi:10.1096%2Ffj.202002413RR/rivista:The FASEB journal (Online)/anno:2021/pagina_da:e21395/pagina_a:/intervallo_pagine:e21395/volume:35
The FASEB journal (Online) 35 (2021): e21395. doi:10.1096/fj.202002413RR
info:cnr-pdr/source/autori:Teresa Borrello M; Rita Emma M; Listi A; Rubis M; Coslet S; Augello G; Cusimano A; Cabibi D; Porcasi R; Giannitrapani L; Soresi M; Pantuso G; Blyth K; Montalto G; Pin C; Cervello M; Iovanna J;/titolo:NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response/doi:10.1096%2Ffj.202002413RR/rivista:The FASEB journal (Online)/anno:2021/pagina_da:e21395/pagina_a:/intervallo_pagine:e21395/volume:35
Background and AimsNon-alcoholic fatty liver disease and related hepatic syndromes affect up to one third of the adult population. The molecular mechanisms underlying NAFL etiology remain elusive. Nuclear Protein 1 (NUPR1) expression increases upon c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cd733e9719455f742cc0ef85de4759e
https://ir.lib.uwo.ca/paedpub/570
https://ir.lib.uwo.ca/paedpub/570
Autor:
Maria Rita Emma, Erika Amore, Maria Luisa Bondì, Melchiorre Cervello, Emanuela Fabiola Craparo, Giuseppa Augello, Chiara Botto
Publikováno v:
International journal of pharmaceutics
(2015). doi:10.1016/j.ijpharm.2015.07.055
info:cnr-pdr/source/autori:M.L. Bondì, C. Botto, E. Amore, M.R. Emma, G. Augello, E.F. Craparo, M. Cervello/titolo:Lipid nanocarriers containing sorafenib inhibit colonies formation into human hepatocarcinoma cells/doi:10.1016%2Fj.ijpharm.2015.07.055/rivista:International journal of pharmaceutics (Print)/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume
(2015). doi:10.1016/j.ijpharm.2015.07.055
info:cnr-pdr/source/autori:M.L. Bondì, C. Botto, E. Amore, M.R. Emma, G. Augello, E.F. Craparo, M. Cervello/titolo:Lipid nanocarriers containing sorafenib inhibit colonies formation into human hepatocarcinoma cells/doi:10.1016%2Fj.ijpharm.2015.07.055/rivista:International journal of pharmaceutics (Print)/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume
Here, the potential of two nanostructured lipid carriers (NLC) for controlled release of sorafenib was evaluated. The obtained systems showed characteristics suitable as drug delivery systems for the treatment of hepatocellular carcinoma (HCC) throug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::431198d0025f9ffb60fa9d1964dcd7fe
http://hdl.handle.net/10447/145300
http://hdl.handle.net/10447/145300
Autor:
Vincenti, V, Amore, Erika, EMMA, Maria Rita, Augello, G, Cervello, M, Bondì, ML, BOTTO, Chiara
Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and the third leading cause of cancer-related deaths. In the United States, the incidence of HCC has almost tripled during the past two decades and HCC has become one of the fas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::83fec52f576c0d273226c827e1ff0151
http://hdl.handle.net/10447/104806
http://hdl.handle.net/10447/104806
Publikováno v:
Nanomedicine VITERBO 2014, Viterbo, September 17-19, 2014
info:cnr-pdr/source/autori:M.L. Bondì, E. Amore, C. Botto, V. Vincenti, M.R. Emma, G. Augello, M. Cervello/congresso_nome:Nanomedicine VITERBO 2014/congresso_luogo:Viterbo/congresso_data:September 17-19, 2014/anno:2014/pagina_da:/pagina_a:/intervallo_pagine
info:cnr-pdr/source/autori:M.L. Bondì, E. Amore, C. Botto, V. Vincenti, M.R. Emma, G. Augello, M. Cervello/congresso_nome:Nanomedicine VITERBO 2014/congresso_luogo:Viterbo/congresso_data:September 17-19, 2014/anno:2014/pagina_da:/pagina_a:/intervallo_pagine
Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and the third leading cause of cancer-related deaths. For the treatment of HCC several drugs are under development, but the only one with proven survival benefit is sorafenib. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::46fa7128ce7de1fa7fb23b2abf89b785
http://hdl.handle.net/10447/104808
http://hdl.handle.net/10447/104808
Autor:
Claudia Pellerito, Tiziana Fiore, Giovanna Barbieri, Maria Assunta Costa, Francesca Zito, Lorenzo Pellerito, Maria Rita Emma
Publikováno v:
International Journal of Oncology. 38
In previous studies we have demonstrated that two derivatives of meso-Tetra(4-sulfonatophenyl)porphine (TPPS), (Bu2Sn)2TPPS and (Bu3Sn)4TPPS, cause apoptotic death of A375 melanoma cells and, at lower concentrations, arrest of cell proliferation. In
Autor:
BARBIERI, G, COSTA, MA, EMMA, Maria Rita, GULINO, L, ZITO, F, FIORE, Tiziana, PELLERITO, Claudia, SCOPELLITI, Michelangelo, PELLERITO, Lorenzo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::55058ac94461f61952c50a99b6a54f78
http://hdl.handle.net/10447/44750
http://hdl.handle.net/10447/44750
Autor:
Abrams SL; Department of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, NC 27858, USA., Duda P; Department of Molecular Physiology and Neurobiology, University of Wrocław, 50-335 Wrocław, Poland., Akula SM; Department of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, NC 27858, USA., Steelman LS; Department of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, NC 27858, USA., Follo ML; Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, 40139 Bologna, Italy., Cocco L; Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, 40139 Bologna, Italy., Ratti S; Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, 40139 Bologna, Italy., Martelli AM; Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, 40139 Bologna, Italy., Montalto G; Department of Health Promotion, Maternal and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.; Institute for Biomedical Research and Innovation, National Research Council (CNR), 90146 Palermo, Italy., Emma MR; Institute for Biomedical Research and Innovation, National Research Council (CNR), 90146 Palermo, Italy., Cervello M; Institute for Biomedical Research and Innovation, National Research Council (CNR), 90146 Palermo, Italy., Rakus D; Department of Molecular Physiology and Neurobiology, University of Wrocław, 50-335 Wrocław, Poland., Gizak A; Department of Molecular Physiology and Neurobiology, University of Wrocław, 50-335 Wrocław, Poland., McCubrey JA; Department of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, NC 27858, USA.
Publikováno v:
Cells [Cells] 2022 Feb 24; Vol. 11 (5). Date of Electronic Publication: 2022 Feb 24.